Trade names from 'baclosan®' to 'bar-vips' - Electronic medicinal guide TALKDRUGS

Powder for solution for intravenous and intramuscular injection 250 mg + 250 mg; 0.5 g + 0.5 g; 1.0 g + 1.0 g.
Solution for oral, local and external use.

Solution for oral, local and external use.

Solution for oral, local and external use.

Capsules, 250 mg and 500 mg.

ATOLL, LLC Russia
Solution for local and external use.

Powder for the preparation of a suspension for oral administration, 125 mg + 31.25 mg / 5 ml; 250 mg + 62.5 mg / 5 ml; 400 mg + 57 mg / 5 ml.

Film-coated tablets, 600 mg.

Suspension for oral administration 240 mg / 5 ml.

Tablets coated with a coating, 960 mg.

Ointment for external use, 2%.

Nasal ointment, 2%.

Powder for solution for intravenous and intramuscular injection 0.5 g + 0.5 g, 1.0 g + 1.0 g, 1.5 g + 1.5 g, 2.0 g + 2.0 g.

Solution for peritoneal dialysis, glucose 1.5% and calcium 1.25 mmol / L, glucose 1.5% and calcium 1.75 mmol / L, glucose 2.3% and calcium 1
Solution for oral, local and external use.

Film-coated tablets, 50 mg and 150 mg.

TAD Pharma GmbH Germany

Ointment for external use 250 IU / g + 5000 IU / g.

Sandoz GmbH Austria

Powder for external use 250 ME / g + 5000 MU / g.

Sandoz GmbH Austria
Powder for the preparation of a suspension for oral administration.